Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03816982 · ClinicalTrials.gov registry record · NA
Interscalene Bupivacaine With Either Liposomal Bupivacaine or Continuous Peripheral Nerve Block for Shoulder Arthroscopy
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT03816982 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 48 participants.
The verdict
NCT03816982, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
This investigation will be a prospective, randomized trial. The study population will consist of adult patients scheduled to undergo major shoulder arthroscopy procedures with anesthesiology at the Ambulatory Services Center (Outpatient Surgery Center). Forty-six subjects will be enrolled in this study and will be randomized into one of two arms: 1) Single-injection bupivacaine HCl plus a subsequent bupivacaine CISB, 2) Single-injection bupivacaine HCl plus liposomal bupivacaine included in the same injection. These procedures will take place, using an ultrasound-guided method, approximately one hour prior to surgical procedure. Subjects will be followed for seven days to assess pain control by the Modified Brief Pain Inventory (MBPI) survey and outcome factors related to study and procedure using the American Shoulder and Elbow Surgeon Shoulder Score (ASES Shoulder Score).
Interventions
- PROCEDURE Single-injection bupivacaine HCl plus liposomal bupivacaine
- PROCEDURE Single-injection bupivacaine HCl plus a subsequent bupivacaine CISB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2019-10-11 |
| Est. Completion | 2022-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03816982
The ClinicalTrials.gov registry entry for NCT03816982 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Single-injection bupivacaine HCl plus liposomal bupivacaine is the first listed.
NCT03816982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03816982 about?
NCT03816982 is a clinical study titled "Interscalene Bupivacaine With Either Liposomal Bupivacaine or Continuous Peripheral Nerve Block for Shoulder Arthroscopy". This investigation will be a prospective, randomized trial. The study population will consist of adult patients scheduled to undergo major shoulder arthroscopy procedures with anesthesiology at the Ambulatory Services Center (Outpatient Surgery Center). Forty-six subjects will be enrolled in this st...
What is the current status of trial NCT03816982?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2019-10-11. Estimated completion is 2022-12-30.
What interventions are being tested in trial NCT03816982?
The interventions under investigation include: Single-injection bupivacaine HCl plus liposomal bupivacaine (PROCEDURE), Single-injection bupivacaine HCl plus a subsequent bupivacaine CISB (PROCEDURE).
Who is sponsoring clinical trial NCT03816982?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.